Showing 1 posts of 1 posts found.
Cambridge Epigenetix (CEGX) on Monday said it has raised about $21 million via Series B financing and named Geoff Smith …
East London pharmacies pilot cholesterol-lowering injections to cut waiting times
Weber is new CMO at Sensorion
Charity commits £800,000 to AI research into late breast cancer recurrence
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
Acumetis CEO Herspiegel steps down as Burden assumes role